ArticleFrontiers in immunology2021

The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring.

Meenu Wadhwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.